CannaBase operates within the regulated cannabis supply chain, connecting verified cultivators, extractors and licensed UK/EU operators through structured, documentation-led supply routes.
The platform focuses on medical cannabis flower, biomass, bulk extracts and vape-grade oils supported by licensing checks, batch documentation and structured buyer introductions. By sitting between supply and procurement, CannaBase helps businesses navigate complex compliance requirements while identifying realistic commercial pathways for regulated cannabis products.
We sit inbetween international cultivators and extractors and UK/EU licence-holders, focusing on documented, brokered routes for medical flower, bulk extracts and vape-grade oils
Cultivators and extractors apply to join CannaBase by submitting site information, licensing credentials, production capabilities and available product formats.
The platform prioritises medical-grade cannabis flower, biomass, bulk oils and extract categories that align with current UK and EU operator demand. Each submission is reviewed to determine whether supply can realistically move through regulated routes based on GACP expectations and downstream processing requirements.
Every listing within CannaBase is documentation-led. Licensing status, batch specifications, origin data, available Certificates of Analysis (COAs), terpene profiles and traceability records are reviewed before supply becomes visible to operators.
Where appropriate, supporting laboratory results and sample readiness are evaluated to give buyers clearer visibility of potential supply before requesting introductions, quotations or commercial discussions.
Verified UK and EU licence-holders—including importers, manufacturers, pharmacies and clinical procurement groups—can access curated supply listings through the platform.
Operators are able to review origin, cannabinoid profile, product format and documentation status before requesting contact with cultivators or extractors. This structured access helps licensed buyers identify supply suited for regulated procurement programmes while maintaining compliance standards across the cannabis supply chain.
Where required, CannaBase helps structure pathways that move GACP-origin cannabis supply into EU-GMP or licensed manufacturing routes through appropriate processing partners.
This provides cultivators with greater visibility on how their batches may progress toward regulated market entry, while allowing operators to identify supply capable of fitting licensed import, manufacturing and distribution frameworks across the UK and EU.
CannaBase is built specifically for regulated medical cannabis trade where documentation quality, route clarity and supply reliability are just as important as product availability.
Verified cultivators, extractors and licensed operators are brought together within a structured B2B environment designed to reduce fragmented sourcing and improve meaningful commercial connections.
Batch data, licensing documentation and available quality records are reviewed before listings are presented to approved operators, improving transparency and reducing unnecessary sourcing friction.
Where possible, listings are assessed for realistic downstream pathways into licensed UK and EU manufacturing or distribution frameworks.
Getting started is straightforward and compliance-focused. Cultivators and extractors submit documentation for review, while approved UK and EU operators gain visibility into supply suited for regulated procurement discussions.
CannaBase supports introductions where product fit, documentation quality and supply route suitability align.